Eosinophil cationic protein in urine in patients with urinary bladder tumors
β Scribed by Lose, G. ;Frandsen, B.
- Publisher
- Springer
- Year
- 1989
- Tongue
- English
- Weight
- 245 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0300-5623
No coin nor oath required. For personal study only.
β¦ Synopsis
Measurement of eosinophil cationic protein (ECP) in urine constitutes a new biochemical method for assessment of local eosinophil activity in the bladder. ECP in urine was measured in 18 patients previously treated for various types of urinary bladder tumors and a comparable control group of 18 normals. The median concentration of ECP in urine from the patients was 46.5 arb. U/l versus 24.5 arb. U/l from normals. This difference was statistically highly significant (p less than 0.01). This study suggests that eosinophils are involved in the host tumor relationship in patients with urothelial neoplasia. Measurement of ECP in urine may imply a new concept for assessment of urothelial tumors.
π SIMILAR VOLUMES
Sixty-nine patients who underwent nephroureterectomy for upper urinary tract transitional cell carcinoma were included in the study. The following data were collected for each patient: grade and stage of renalhreteral tumor, tumor location, timing of tumor appearance and recurrence in the bladder, g
Two hundred and twenty-four biopsies from 151 patients with urinary bladder neoplasms have been studied in order to investigate the incidence of and possible causes for the infiltration of eosinophils. Cases of schistosomiasis were excluded from this study. Of these biopsies, 16 showed a heavy infil
Isozymes of urinary lactic dehydrogenase (LDH) were studied in 55 subjects, including 17 patients with bladder tumors. Normal clear urine from healthy persons showed little activity of LDH5, but in 11 out of 17 patients with bladder tumors LDH5 was increased sufficiently to invert the ratio of LDH5/